Friday, December 14, 2018
Tags Aducanumab

Tag: aducanumab

Eisai Co Ltd Representative Corporate Officer and CEO Haruo Naito attends a news conference at the company headquarters in Tokyo

Eisai Clinches Merck Deal to Develop and Sell Cancer Drug, Shares...

By Bill Berkrot and Sam Nussey NEW YORK/TOKYO (Reuters) Merck & Co Inc and Japan's Eisai Co Ltd have signed a potential multibillion-dollar collaboration to...